Table 1.
To use advanced imaging methods to examine atherosclerosis in the coronary and carotid arteries together with information obtained by proteomics/metabolomics/genomics technologies to improve risk prediction for CVD |
To use advanced imaging methods to examine pulmonary tissue in combination with functional measurements and information obtained by proteomics/metabolomics/genomics technologies to improve diagnosis and risk prediction for COPD |
To use advanced imaging methods to examine fat deposits together with information obtained by proteomics/metabolomics/genomics technologies to improve understanding of the role of obesity and diabetes in CVD and COPD |
To improve the understanding of the epidemiology of CVD and COPD |
To improve the understanding of underlying mechanisms of disease in CVD and COPD |
To evaluate the cost‐effectiveness and ethics of using new imaging methods and proteomics/metabolomics/genomics technologies in prevention of CVD and COPD |
CVD, cardiovascular disease; COPD, chronic obstructive pulmonary disease.